Sort by: Date added | Date Published | Most Viewed

Headlines Tagged with Vaccines 1,142 headlines found

7 Views

Pfizer Has a Revenue-Boosting Treatment to Help Smokers Quit

Wall Street analysts estimate that Chantix’s sales in 2016 will reach ~$0.9 billion, which would be a year-over-year (or YoY) decline of ~28%. The strong growth is mainly attributed to robust sales anticipated in the US market due to increasing demand an
Market Realist
added Oct 22, 2016 20:27
7 Views

New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?

Many of these products are in the early stages of clinical trials; however, cytisine looks most promising in having established efficacy and safety with low cost. Electronic cigarettes have become very popular, appear to be efficacious and are safer than
CNS Drugs
added Oct 7, 2016 17:32
7 Views

[Canada] This may be exactly what smokers need to quit

Le and his team are proposing to develop a new vaccination strategy targeting the lungs, which offers an effective treatment that can sequester nicotine in the airways and limit its entry into the brain. Preliminary results show that levels of nicotine
BayToday.ca (ca)
added Sep 30, 2016 22:10
7 Views

FDA Panel Splits on Softening Chantix Warning

10 voted to remove the warning, four voted to modify warning language to reflect results from a recently completed postmarketing trial and five wanted the warned to stay unchanged. FDA does not have to honor the committees' vote, and a vote this close is
MedPage Today
added Sep 15, 2016 18:12
7 Views

‘The stop-smoking pill made me do it': Man found not criminally responsible for shooting wife

Pfizer, the maker of Chantix, has denied that the drug has any neuropsychiatric effects. But McClatchy News Service reported in 2014 that more than 2,000 people had joined in lawsuits against Pfizer for various psychiatric problems, including suicide and
Washington Post
added Aug 9, 2016 17:03
7 Views

CHAMPIX® (Varenicline) European Union Label Updated To Include New Safety And Efficacy Data From The EAGLES Clinical Trial Following Endorsement From CHMP

Pfizer Inc. (NYSE:PFE) today announced that the European Summary of Product Characteristics (SmPC) and Package Leaflet for CHAMPIX® (varenicline) have been updated to include safety and efficacy data from the EAGLES (Evaluating Adverse Events in a Global
Pfizer
added May 24, 2016 15:46
7 Views

[North Carolina] Tobacco leaves may provide production option for flu vaccine

Medicago Inc. also is using its tobacco plant research to develop drugs to combat the Sudan strain of the Ebola virus. It has signed production contracts with the Canadian and U.S. governments. "Preliminary results have shown that Medicago’s technology c
Winston-Salem (NC) Journal
added Mar 16, 2016 09:55
7 Views

Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks / A Randomized Clinical Trial

Among adults motivated to quit smoking, 12 weeks of open-label treatment with nicotine patch, varenicline, or C-NRT produced no significant differences in biochemically confirmed rates of smoking abstinence at 26 weeks. The results raise questions about t
Journal of the American Medical Association (JAMA)
added Jan 28, 2016 15:08
7 Views

Varenicline helps smokers with stable depression

Varenicline successfully promoted durable smoking cessation without exacerbating depression or anxiety in a randomized, phase IV, industry -funded study of patients with stably treated major depressive disorder.
Philippine Star (ph)
added May 10, 2015 16:02
7 Views

Quit-Smoking Products Won't Harm the Heart, Review Finds

But patients should not keep smoking while on nicotine-replacement therapy, experts warn
HealthDay [HealthScout]
added Dec 10, 2013 17:30
Sign up for daily headlines All Headlines Featured Headlines U.S. Headlines International Headlines